Determinants of psychopharmacological multimedication in unipolar and bipolar depression

Determinants of psychopharmacological multimedication in unipolar and bipolar depression - Multimedication for depression

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00036402

Enrollment

576

Registered

2025-03-18

Start date

2025-06-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unipolar depression and bipolar depression (F32.X, F33.X, F31.3, F31.4, F31.5)

Interventions

Group 1: unipolar depression Group 2: bipolar depression

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Main diagnosis on discharge unipolar depression or bipolar depression (ICD 10 F32.X, F33.X, F31.3, F31.4, F31.5) Day clinic treatment /full inpatient treatment Survey period 2022-2023

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Proportion of patients with unipolar or bipolar depression and psychopharmacological multi-medication	—

Secondary

Measure	Time frame
Identification of possible determinants of psychopharmacological multimedication (age, gender, duration of illness, duration of episode during index stay, duration of index stay, number of previous stays)	—

Countries

Germany

Contacts

Public ContactHans-Jörg Assion

LWL Klinik Dortmund

Hans-Joerg.Assion@lwl.org+49 231 4503 3227

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026